High-throughput mutagenesis identifies mutations and RNA-binding proteins controlling CD19 splicing...
Nature Communications - Multiple alternative splicing events in CD19 mRNA have been associated with resistance/relapse to CD19 CAR-T therapy in patients with B cell malignancies. Here, by combining...
nature.com